November/December 2014
Biopharma Asia
November/December 2014 | Volume 3 Issue 6
Risk-Based Extractable Data Assessment and its Application to the Evaluation of Materials ...
By: Ping Wang, Principal Scientist Janssen R&D
Reducing Microbiological Risk and Using Quality Tools in the Pharmaceutical Industry
By: Donald Singer, Global Lead Quality Manager, Microbiology R&D GlaxoSmithKline
Supply Chain Security Risks
By: Brian Johnson, Senior Director of Supply Chain Security Pfizer
Challenges and Recent Developments in Administration Devices for Paediatrics
By: Jenny Walsh, Director Jenny Walsh Consulting Deborah Bickmann, Team Lead Process Dev...
Achieving Compliance in OTC Advertising and Labelling Regulations in Asia
By: Rashmi Kulshrestha, Founder and CEO Regulatory Wisdom Rameez Raja, Assistant Manage...
















